冠状动脉不同分支慢性完全闭塞病变再血管化后中远期预后及其影响因素分析
作者:
作者单位:

(江苏大学附属医院心内科,江苏省镇江市 212001)

作者简介:

时小凤,硕士研究生,E-mail为shixiaofeng1992@126.com。通信作者王昭军,博士,主任医师,硕士研究生导师,主要研究方向为动脉粥样硬化,E-mail为doctorwang1965@163.com。

基金项目:

镇江市重点(医卫)项目(SH2015029)


Comparison of middle and long term effects after PCI revascularization in patients with chronic total occlusion of different branches of coronary artery
Author:
Affiliation:

Department of Cardiology, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212001, China)

  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
    摘要:

    目的 比较分析冠状动脉不同分支慢性完全闭塞病变(CTO)行经皮冠状动脉介入治疗(PCI)再血管化后的中远期预后及其影响因素。方法 纳入经选择性冠状动脉造影证实为CTO的患者共122例,按照CTO病变部位[左前降支(LAD)、左回旋支(LCX)、右冠状动脉(RCA)]分为不同分支病变,对其中113例患者实施PCI。随访观察PCI成功再血管化组与同期未再血管化组(包括PCI未成功及未行PCI)患者的中远期预后,包括生存率、主要不良心脏事件(MACE)、左心室功能;比较不同分支CTO病变再血管化后中远期效果的差异,并分析影响预后的临床因素。结果 113例行PCI的CTO患者中81例成功再血管化(其中RCA病变30例,LAD病变 32例,LCX病变 5例,两支及多支病变14例)。在随访期内[(26.7±20.7) 月],成功再血管化组总的累积无事件生存率显著高于未再血管化组(70.4%比58.5%,P=0.042),不良事件总发生率显著低于未再血管化组(24.7%比56.1%,P=0.021)。全部CTO病例成功再血管化后总的左心室射血分数(EF)增加值[(3.1±1.4)%]与未再血管化组[(0.3±1.2)%]比较,差异有统计学意义(P=0.038)。RCA病变、LAD病变、两支及多支病变成功再血管化组不良事件发生率明显低于未再血管化组(P分别为0.002、0.017、0.013),LCX病变患者两组间差异无统计学意义(P=0.408)。RCA病变、LAD病变成功再血管化组ΔEF[分别为(3.6±1.7)%、(4.1±1.8)%](P分别为0.045、0.038)、左心房内径变化值(ΔLAD,P分别为0.031、0.035)、左心室舒张期末内径变化值(ΔLVEDD,P分别为0.012、0.024)、左心室收缩期末内径变化值(ΔLVESD,P分别为0.018、0.031)及右心房内径变化值(ΔRAD,P分别为0.037、0.028),与未再血管化组相比差异有统计学意义,而LCX病变、两支及多支病变成功再血管化组ΔEF[分别为(0.6±0.3)%、(0.8±0.3)%](P分别为0.115、0.475)、ΔLAD(P分别为0.315、0.236)、ΔLVEDD(P分别为0.287、0.381)、ΔLVESD(P分别为0.348、0.341)及ΔRAD(P分别为0.126、0.256),与未再血管化组相比差异无统计学意义。Cox比例风险回归分析显示,影响CTO患者PCI再血管化后中远期生存预后的因素包括:糖尿病史(95%CI:1.253~8.449,P=0.015)、血清总胆红素(95%CI:0.874~0.996,P=0.038)、血尿酸水平(95%CI:1.001~1.007,P=0.006)和J-CTO评分(95%CI:1.135~5.325,P=0.012)。 结论 冠状动脉CTO病变行PCI成功再血管化可提高患者中远期总的累积无事件生存率,但不同分支CTO病变再血管化后再发心绞痛、心力衰竭、MACE事件、全因死亡发生率及左心室EF的改善存在差异;糖尿病史、CTO评分偏高可显著增加CTO患者的中远期死亡风险。

    Abstract:

    Aim To compare the middle and long term prognosis and analyze the influencing factors of chronic total occlusion (CTO) in different branches of coronary artery after percutaneous coronary intervention (PCI) revascularization. Methods A total of 122 patients with CTO confirmed by selective coronary angiography were divided into different branches of lesions according to the lesion location of CTO(left anterior descending artery (LAD), left circumflex artery (LCX), and right coronary artery (RCA)). 113 of them were tried to implement PCI, and the prognosis (survival rate, major adverse cardiac events, left ventricular function) of those with successful PCI and non-revascularization (including unsuccessful PCI and non-PCI) were observed through following up. The middle and long term effects of different branches of CTO after revascularization were compared, and the clinical factors that affect the prognosis were analyzed. Results Among the 113 CTO patients who underwent PCI, 81 cases were successfully revascularized (including 30 cases of RCA, 32 cases of LAD, 5 cases of LCX and 14 cases of two or more branches lesions). The cumulative event-free survival rate in the successful PCI revascularization group was significantly higher than that in the non-revascularization group (70.4% vs 58.5%, P=0.042) during the mean follow-up of (26.7±20.7) months, and the total incidence of adverse events was significantly lower than that in the non-revascularization group (24.7% vs 56.1%, P=0.021). In RCA group, LAD group and two or more CTO lesions group, the incidence of recurrent angina pectoris, heart failure, MACE and all-cause death in those successfully treated with revascularization were significantly lower than that of non-revascularization group (P value of these groups was 0.2,0.7,0.013, respectively). There was no significant difference in LCX group (P=0.408). The total increased left ventricular EF ((3.1±1.4)%) after successful PCI in all patients with CTO was significantly higher than that in the non-revascularization group ((0.3±1.2)%, P=0.038). The ΔEF ((3.6±1.7)%, (4.1±1.8)%,Pü value =0.5,0.038), ΔLAD (P value =0.1,0.035), ΔLVEDD (P value=0.2,0.024), ΔLVESD (P value=0.8,0.031) and ΔRAD (P value=0.7,0.028) after successful revascularization in the RCA group and LAD group was significantly different compared with the same group of patients without revascularization. There was no significant difference about ΔEF(P value=0.5,0.475), ΔLAD (P value = 0.5,0.236), ΔLVEDD (P value=0.7,0.381), ΔLVESD (P value =0.8,0.341), ΔRAD (P value =0.6,0.256) in LCX group and two or more branches group after successful PCI revascularization. Cox proportional risk regression analysis showed that the prognostic factors of CTO patients after PCI revascularization included diabetes history (95%CI:1.253~8.449, P=0.015), serum total bilirubin (95%CI:0.874~0.996, P=0.038), serum uric acid levels(95%CI:1.001~1.007, P=0.006) and J-CTO scores (95%CI:1.135~5.325, P=0.012). Conclusions Successful PCI revascularization of coronary CTO lesions can improve the overall cumulative event-free survival rate in the middle and long term. However, there are differences in the incidence of recurrent angina pectoris, heart failure, MACE, all-cause death and the improvement of left ventricular EF in different branches of CTO lesions. Diabetes history and higher J-CTO scores increases the risk of middle and long term death in CTO patients.

    参考文献
    引证文献
引用本文

时小凤,王昭军,严金川,沈俊飞,邵海锐.冠状动脉不同分支慢性完全闭塞病变再血管化后中远期预后及其影响因素分析[J].中国动脉硬化杂志,2019,27(2):141~149.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2018-07-26
  • 最后修改日期:2018-10-11
  • 在线发布日期: 2019-01-21